Related Experiment Video

Updated: Jul 29, 2026

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease

S D Robinson1, S A Harding, P Cummins

  • 1Centre for Cardiovascular Science, University of Edinburgh, UK. simon.robinson@ed.ac.uk

Platelets
|May 17, 2006
PubMed

Insights

In patients with coronary heart disease (CHD), higher platelet activation markers correlate with reduced endothelium-dependent vasodilation. This link between platelet activation and endothelial dysfunction may explain increased atherothrombotic event risk.

Area of Science:

  • Cardiovascular Research
  • Hematology
  • Vascular Biology

Background:

  • Platelet activation, indicated by platelet-monocyte binding and P-selectin expression, is crucial in atherothrombosis.
  • Endothelium-derived factors possess anti-atherothrombotic properties by inhibiting platelet activation.

Purpose of the Study:

  • To investigate the relationship between platelet activation and endothelium-dependent vasomotion in patients with coronary heart disease (CHD).

Main Methods:

  • Assessed platelet activation using two-colour flow cytometry for platelet-monocyte binding and P-selectin expression.
  • Measured forearm blood flow via venous occlusion plethysmography during intra-arterial infusions of substance P, acetylcholine, and sodium nitroprusside in CHD patients and healthy controls.

Main Results:

  • Patients with CHD exhibited significantly higher platelet activation compared to healthy men.
  • An inverse correlation was found between maximal substance P-induced vasodilation and both platelet-monocyte binding and P-selectin expression in CHD patients.
  • A similar inverse correlation was observed between platelet-monocyte binding and acetylcholine-induced vasodilation, but not with sodium nitroprusside.

Conclusions:

  • A significant inverse relationship exists between platelet activation markers and endothelium-dependent vasomotor function in stable coronary heart disease.
  • This finding suggests a potential pathophysiological mechanism linking endothelial vasomotor dysfunction and the heightened risk of acute atherothrombotic events in CHD.

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...